You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《大行報告》富瑞下調歐舒丹(00973.HK)目標價至30.2元 評級「買入」
阿思達克 06-27 10:33
富瑞發表研究報告指,歐舒丹(00973.HK)管理層指引,由2024財年起將營銷費用提高到銷售額的約20%,會重點投資於核心歐舒丹品牌和Elemis。憑藉新產品配方及新市場渠道,目標是維持2026財年的銷售30億歐元和營運利潤率達16%的目標。該行將目標價由34.7元下調至30.2元,維持「買入」評級。 該行表示,由於集團對2024財年有較低的營運利潤率指引,分別下調其2024及25財年淨利潤16%和8%。而該行對公司2026財年的預測剛大致符合市場及管理層的預期。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account